NCT06528301
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06528301
Title A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Umoja Biopharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
City of Hope NOT_YET_RECRUITING Duarte California 91010 United States Details
The David and Etta Jonas Center for Cellular Therapy RECRUITING Chicago Illinois 60637 United States Details
Washington University School of Medicine/Siteman Cancer Center RECRUITING St Louis Missouri 63110 United States Details
University of Nebraska Medical Center RECRUITING Omaha Nebraska 68198-6814 United States Details
University of Cincinnatti Medical Center RECRUITING Cincinnatti Ohio 45219 United States Details
Fred Hutch Cancer Center RECRUITING Seattle Washington 98109 United States Details
Royal North Shore Hospital RECRUITING Saint Leonards New South Wales 2065 Australia Details
St. Vincent's Hospital Melbourne RECRUITING Fitzroy Victoria 3065 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field